Q. Qian

Oncogenic secretory clusterin in hepatocellular carcinoma: Expression at early staging and emerging molecular target.

Wei Wu, Z. Dong, Wenjie Zheng, 2017, Oncotarget.

Glypican-3 is a biomarker and a therapeutic target of hepatocellular carcinoma.

Li Wang, M. Yao, D. Yao, 2015, Hepatobiliary & pancreatic diseases international : HBPD INT.

Glypican-3 as an emerging molecular target for hepatocellular carcinoma gene therapy

Z. Dong, Wenjie Zheng, Li Wang, 2014, Tumor Biology.

Silencing clusterin gene transcription on effects of multidrug resistance reversing of human hepatoma HepG2/ADM cells

Yao Yao, Wenjie Zheng, M. Yao, 2015, Tumor Biology.

Diagnostic and prognostic significance of secretory clusterin expression in patients with hepatocellular carcinoma

Wei Wu, Jianfei Huang, Wenjie Zheng, 2015, Tumor Biology.

Encouraging microRNA-based Therapeutic Strategies for Hepatocellular Carcinoma.

Li Wang, M. Yao, L. Qiu, 2015, Anti-cancer agents in medicinal chemistry.

The pck rat: a new model that resembles human autosomal dominant polycystic kidney and liver disease.

V. Torres, Q. Qian, M. Ishibashi, 2001, Kidney international.